InflammaDry MMP-9 Tränenfilm-Test (Pack of 20 single tests)

Article number: 7999002

Product description

Identify Dry Eye

An In-Office test to aid in Dry Eye diagnosis

Dry eye disease, or dysfunctional tear syndrome, is an extremely common condition that is often under diagnosed and affects 5-30% of the population ages 50 and over. (1)

InflammaDry® is the first and only, rapid, in-office test that detects MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease. (2)

Commit to making the right diagnosis with an easy-to use, in-office, dry eye test that gives accurate results in just 10 minutes.

85% Sensitivity (3)

94% Specificity (3)

Right Diagnosis

  • MMP-9 is a more sensitive diagnostic marker for dry eye than clinical signs alone. (2)
  • Inflammation is present before the clinical signs of dry eye. (4)
  • Increased MMP-9 activity in dry eyes may contribute to deranged corneal epithelial barrier function, increased corneal desquamation, and corneal surface irregularity. (4)

    Right Treatment

  • Dry eye disease may require an extensive treatment plan and continuous therapy.
  • Artificial tears and punctal occlusion may improve signs and symptoms, while helping to decrease visual irritation. (5)
  • Anti-inflammatory therapies, such as cyclosporine, corticosteroids, and doxycycline have been shown to decrease MMP-9 activity. (6)

    Right Now

  • Results in 10 minutes.

    InflammaDry is the only rapid, in-office dry eye test that detects MMP-9, a biomarker for inflammation that is consistently elevated in the tears of dry eye patients. (2) All other dry eye tests measure tear production and stability.

    InflammaDry recognizes elevated levels of MMP-9 to identify patients that may otherwise be missed with other dry eye testing methods.

    Inflamma-Dry

  • Detects elevated levels of MMP-9 in tear fluid, to identify inflammation.
  • Provides rapid results in just 10 minutes.
  • Accurate, with higher positive agreement (sensitivity) and higher negative agreement (specificity) than other dry eye tests.

    Clinical Benefits of identifying Dry Eye

  • By identifying and treating patients with dry eye, pre-surgical measurements are more accurate and post-surgical outcomes are improved. (7)
  • Reduce post-surgical complications, such as corneal wound healing, by identifying dry eye prior to surgery. (4)
  • Therapeutic treatment of Dry Eye will improve patient quality of life. (8)

    Confidence in Dry Eye diagnosis

  • Disposable, in-office diagnostic test that requires just 4 easy steps.
  • Low cost test requires no additional equipment to administer or interpret.

    You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

    More Information

    Unblock content Accept required service and unblock content

    References



    [1] The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf.
    2007 Apr;5(2):93-107.

    [2] Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in
    dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3203-9.

    [3] RPS InflammaDry sensitivity and specificity was compared to clinical truth in RPS clinical study: protocol #100310.

    [4] Sambursky R, O’Brien TP. MMP-9 and the perioperative management of LASIK surgery. Curr Opin Ophthalmol. 2011 Jul;22(4):294-303.

    [5] Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Ophthalmology. 1999 Apr;106(4):811-6.

    [6] Kaufman HE. The practical detection of mmp-9 diagnoses ocular surface disease and may help prevent its complications. Cornea. 2013
    Feb;32(2):211-6.

    [7] Shtein RM. Post-LASIK dry eye. Expert Rev Ophthalmol. 2011 Oct;6(5):575-582.

    [8] Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003 Jul;110(7):1412-9.

    • €335,00
    Excl. 19% Tax, excl. Shipping Cost
    Quantity
    -
    +
    SKU: 7999002 Category:
    Manufacturer: RPS Rapid Pathogen Screening, Inc.7227 Delainey Court • Sarasota, FL 34240 USA
    EU rep.: MT Medical Technology Promed Consulting GmbH, Altenhofstrasse 80, 66386 St. Ingbert